For instance, curcumin, a natural antioxidant, has demonstrated enhanced anticancer effects when combined with EGFR inhibitors in preclinical models of non-small cell lung cancer (NSCLC), helping to overcome tumor resistance [213]. Here, EGFR is linked to non-small cell lung carcinoma.